Articles from Rocket Doctor AI Inc.

VANCOUVER, British Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) has entered into a digital advisory agreement (the “Agreement”) to retain B2i Digital, Inc. ("B2i Digital"), a New York corporation, to provide digital marketing advisory services, subject to the approval of the Canadian Securities Exchange (the "Exchange").B2i Digital will provide investor-focused digital marketing advisory services, including building and maintaining a featured company profile on b2idigital.com, creating and managing paid digital advertising campaigns, developing investor-focused content and creative materials, distributing content across social media channels, conducting email marketing campaigns to the investing community, and connecting the Company with relevant investor conferences and speaking opportunities."We are excited to be featured in B2i Digital’s program. This collaboration is a pivotal element of our strategic initiative to broaden our presence across the US, including New York, ensuring our physician-built, AI-powered solutions reach those who need them most," said Dr. Essam Hamza, CEO of Rocket Doctor AI.The promotional activity will be conducted across the following platforms and mediums:

Vancouver, British Columbia, July 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) today announced that its wholly owned subsidiary, Rocket Doctor, Inc., has extended its engagement with EngageWell to continue expanding access to physician-led care for underserved communities across New York City. This follows the successful completion of the New York Health Foundation-funded "Virtual Pathway to Care" initiative.This renewed investment shifts the focus from demonstrating what's possible to creating a more sustainable model for community-based virtual care. By combining philanthropic support with Medicaid reimbursement where appropriate, Rocket Doctor and EngageWell will continue providing no-cost telemedicine services to uninsured and underinsured New Yorkers while validating a scalable pathway that can expand access to physician-led virtual care well beyond the initial pilot.The initial pilot program exceeded its program goals, connecting more than 400 underserved New Yorkers to physician-led virtual urgent care, preventive health consultations, psychiatric evaluations, and primary care navigation through trusted community-based organizations.“This next phase is about building on a model that has already demonstrated meaningful community impact," said Dr. William Cherniak, Co-Founder and Chief Executive Officer of Rocker Doctor, Inc. "Our work with EngageWell has shown that when physicians, technology, and trusted community organizations come together, we can reach patients who are often left outside the traditional healthcare system. Our focus now is on creating sustainable reimbursement pathways that will allow this model to grow and become a lasting part of how healthcare is delivered.”The extended engagement builds on the organization’s shared commitment to combining trusted community relationships with accessible, technology-enabled care. By pairing grant support with a growing reimbursement pathway, Rocket Doctor and EngageWell are working to preserve access for underserved patients while creating a stronger foundation for long-term program continuity. The extended agreement took effect on July 1, 2026, and aligns with the underlying grant-funded telehealth initiatives through October 31, 2029."For the people we serve, the greatest barrier often isn't technology - it's access," said Christopher Joseph, Executive Director of EngageWell. "This partnership demonstrates that when trusted community organizations are equipped with modern telemedicine, we can reach people who have historically been left out of the healthcare system and connect them to the care they need. We're proving that this model works. Now it's time to build sustainable reimbursement pathways so every community has access to these innovative models of care."The renewed engagement complements the partners’ ongoing Healthy Aging Program, supported by funding from the CVS Health Foundation. That initiative serves adults aged 60 and older through virtual heart health consultations, mental health and cognitive assessments, physician follow-up and referrals to additional care. The current program period extends through October 31, 2029, with targets that include 750 mental health assessments, 750 cognitive health assessments and 750 heart health consultations, all free of cost to participants.The extended collaboration reflects Rocket Doctor’s broader strategy of working with community organizations, healthcare providers and payers to improve access to physician-led care while transitioning successful grant-funded pilots toward sustainable reimbursement models.About the EngageWell NetworkFounded by nonprofit health and human services organizations serving New York City's most vulnerable communities, the EngageWell Network brings together community-based organizations, healthcare providers, managed care organizations, and technology partners to transform how care is delivered. Through EngageWell Community Health & Innovation Collaborative (CHIC) and EngageWell IPA, a New York State-designated Behavioral Health Care Collaborative, the network develops innovative programs that integrate healthcare, behavioral health, health-related social needs, and digital health solutions to improve outcomes and reduce health disparities. Together, the EngageWell Network is building sustainable, community-driven models of care that break down barriers to health and wellbeing. Learn more at www.engagewellnetwork.com or contact christopher@engagewellipa.com. About Rocket Doctor AI Inc. Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 750,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care. By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.To learn more about Rocket Doctor AI Inc’s products and services, contact:www.rocketdoctor.ai  or email: info@rocketdoctor.ai FOR ADDITIONAL INFORMATION, CONTACT:Dr. Essam Hamza, CEO, Rocket Doctor AIessam.hamza@rocketdoctor.aiDr. Bill Cherniak, CEO, Rocket Doctor Inc.bill@rocketdoctor.io For media inquiries, contact: media@rocketdoctor.ai Call: +1 (778) 819 8321Cautionary StatementsThis news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will," "may," "should," "anticipate," "expects," and similar expressions. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding the anticipated benefits of the Company's extended engagement with EngageWell IPA, including the expected outcomes of the New York Community Trust-funded program, the anticipated number of telemedicine visits and primary care navigations to be supported under the program, the Company's ability to bill Medicaid directly where eligible, and the development of a sustainable reimbursement model for underserved communities, the Company's continued expansion of its physician network and patient visit volumes across North America, and the future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include the risk that the extended engagement with EngageWell IPA may not achieve the anticipated program outcomes or targeted number of telemedicine visits, risks relating to the availability and continuity of grant funding from the New York Community Trust or other funders, risks relating to the Company's ability to obtain Medicaid billing eligibility or to generate anticipated reimbursement revenues, risks relating to changes in healthcare policy or Medicaid regulation in the United States, risks relating to the Company's ability to continue expanding its physician network and platform across Canada and the United States, risks relating to the competitive landscape for AI-powered digital health solutions, risks relating to cybersecurity and data privacy regulation in Canada and the United States, and other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

Vancouver, BC, July 21, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI" or the "Company") today announced that its wholly owned digital health platform and marketplace subsidiary, Rocket Doctor Inc., has joined the Alliance for Connected Care's Telehealth Voters Pledge, a growing national coalition advocating for permanent Medicare telehealth legislation in the United States.

Vancouver, BC, July 14, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has successfully achieved SOC 2 Type I compliance, demonstrating the Company's ongoing commitment to maintaining rigorous standards of security, privacy, and operational excellence.

Vancouver, BC, July 23, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) today announced that its wholly owned digital health platform and marketplace subsidiary, Rocket Doctor Inc., has been selected as one of Canada’s Top 100 AI & Tech Startups for ALL IN 2026, Canada’s largest event dedicated to artificial intelligence and advanced technologies.Selected from more than 330 applicants, Rocket Doctor Inc. was recognized for the strength of its innovation and its contribution to advancing Canada’s artificial intelligence and technology ecosystem. The company will showcase its platform at ALL IN 2026 in Montréal on September 16 and 17.The recognition reflects Rocket Doctor Inc.’s continued advancement of physician-led, AI-enhanced solutions designed to improve healthcare access, reduce administrative burden and support better clinical decision-making. Through its digital health platform and marketplace, proprietary software and intelligent clinical workflows, Rocket Doctor Inc. helps physicians deliver more efficient, connected and accessible care across Canada and the United States.Rocket Doctor Inc.’s platform currently supports more than 350 physicians and has enabled more than 750,000 patient visits across North America. The company continues to expand its work with healthcare systems, governments, pharmacies, medical schools, employers and insurers, while maintaining a strong focus on rural, remote and underserved communities.“We’re honoured to see Rocket Doctor recognized among Canada’s Top 100 AI & Tech Startups,” said Dr. William Cherniak, Co-Founder and Chief Executive Officer of Rocket Doctor Inc. “Our focus has always been on giving physicians better tools, reducing friction in care delivery and helping more patients access the support they need. Artificial intelligence is most valuable when it pairs with physicians to help solve real healthcare challenges. This recognition by ALL IN reflects the work of our entire team, and the real-world impact our platform is already having on improving patient care across North America.”At ALL IN 2026, Rocket Doctor Inc. will demonstrate how its platform supports clinical workflows, intelligent patient intake and triage, care coordination and expanded access to physician-led healthcare. The company will also meet with healthcare leaders, investors, technology partners and policymakers to explore new opportunities for collaboration and growth.ALL IN is Canada’s largest event dedicated to artificial intelligence and advanced technologies, bringing together more than 7,500 participants from over 40 countries, including global technology leaders, investors, researchers, startups and public-sector organizations. Rocket Doctor Inc. will exhibit alongside Canada’s most promising AI companies as part of the Top 100 AI & Tech Startups showcase.About Rocket Doctor AI Inc. Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 350 MDs to provide care to more than 750,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care. By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.To learn more about Rocket Doctor AI Inc’s products and services, contact:www.rocketdoctor.ai  or email: info@rocketdoctor.ai FOR ADDITIONAL INFORMATION, CONTACT:Dr. Essam Hamza, CEO, Rocket Doctor AIessam.hamza@rocketdoctor.aiDr. Bill Cherniak, CEO, Rocket Doctor Inc.bill@rocketdoctor.io For media inquiries, contact: media@rocketdoctor.ai Call: +1 (778) 819 8321

Vancouver, BC, July 07, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI") is pleased to announce the appointment of Mr. Andrew Lau, CPA, CA as Chief Financial Officer, effective July 6, 2026. This strategic addition to the executive team follows Rocket Doctor AI’s recent U.S. expansion, which increased the company's access to over 21 million covered lives. Mr. Lau’s leadership will be instrumental in managing the financial complexities of this rapid scaling and driving the company’s expansion strategy.

Vancouver, BC, June 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI" or the "Company") today announced that its wholly owned digital health platform and marketplace subsidiary, Rocket Doctor Inc., has entered into its first value-based primary care provider agreement alongside a specialty services agreement with a California independent physician association (IPA).

Vancouver, BC, June 23, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has entered into a partnership with Mindstride AI, designed to improve access to timely, connected healthcare for patients across Ontario, Alberta and British Columbia. Through the partnership, physicians on Rocket Doctor will provide after-hours and overflow coverage for Mindstride patients, helping ensure individuals can access medical care when they need it, even outside regular clinic hours or during periods of increased demand.

Vancouver, BC, June 18, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality, affordable care, today announced the first activation of its national motorsports marketing partnership with Rick Ware Racing and FinTekk AP. Rocket Doctor AI will serve as the primary sponsor of Rick Ware Racing’s No. 51 Chevrolet, driven by Cody Ware in the inaugural Anduril 250 NASCAR Cup Series race Sunday at Qualcomm Circuit on Naval Base Coronado in San Diego.

Delaware, June 16, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality affordable care, today announced that its U.S.-based subsidiary, Treatment.com Inc. (“Treatment”), in collaboration with Rush River Research, has received confirmation of second-year funding from the National Institute on Minority Health and Health Disparities, part of the National Institutes of Health (“NIH”).

Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) has granted an aggregate 47,013 stock options, exercisable at $0.71 per share and valid for a term of three years, and an aggregate 514,801 restricted share units, valid for a term between one to three years, to consultants and employees of the Company and its subsidiaries.  The stock options and restricted share units are issued pursuant to the Company’s share compensation plans and are subject to a statutory hold period of four months and one day from issuance, in addition to vesting provisions.Additionally, and further to the Company’s news release dated July 18, 2025, the Company has extended the marketing services provided by 45 Degrees, Inc. (“45 Degrees”) and Investment Publishing LLC (“Investment Publishing”) to provide digital marketing and investor awareness services until September 30, 2026. No additional compensation shall be payable to 45 Degrees or Investment Publishing for the additional services provided.

Vancouver, BC, June 08, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality affordable care, is pleased to announce that it has entered into a definitive Marketing Agreement (the "Agreement") with Rick Ware Racing, LLC ("RWR") and FINTEKK AP, LLC ("FTEK") and together with RWR, (the "Marketing Partners"), dated effective June 5, 2026 for the provision of product marketing and brand awareness services, specifically the 2026 NASCAR Cup Series.

Vancouver, BC, June 02, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it has filed its audited financial statements for the first quarter ended March 31, 2026. The Company’s financial statements and Management’s Discussion and Analysis (“MD&A”) are available under its profile on SEDAR+ at www.sedarplus.ca.

Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it will host a comprehensive Company Town Hall on Wednesday, June 3, 2026.

Vancouver, BC, May 19, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, subject to regulatory approval, it has entered into an agreement dated May 15, 2026 with North Star Investor Relations Inc. (“North Star”) pursuant to which the Company has engaged the services of North Star to provide investor relations and marketing services, beginning on May 15, 2026. 

Vancouver, BC, May 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has entered into a partnership with the University of Toronto to support clinical education for students enrolled in its Physician Assistant (PA) program. Through this collaboration, first-year PA students from the University of Toronto’s program will complete part of their required first-year observerships by participating in Rocket Doctor clinics. The first clinic launched on April 14, 2026.

Vancouver, BC , May 04, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality care, is pleased to announce that it has filed its audited annual financial statements for the fiscal year and fourth quarter ended December 31, 2025. The Company’s financial statements and Management’s Discussion and Analysis (“MD&A”) are available under its profile on SEDAR+ at www.sedarplus.ca.

Vancouver, BC, April 29, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that Dr. William Cherniak, Founder and Chief Executive Officer of its operating subsidiary, Rocket Doctor Inc. (“Rocket Doctor”), has been selected to participate in the Canadian Life Sciences Trade Mission to New York and New Jersey, taking place May 11–14, 2026. Dr. Cherniak will represent Rocket Doctor as part of a Canadian delegation engaging with U.S. healthcare leaders, investors, and strategic partners to support the Company’s U.S. expansion strategy.

Vancouver, BC, April 21, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with a major national payer in Maryland, expanding access to care for approximately 250,000 additional members across both Commercial and Medicare Advantage lines of business, bringing total coverage across the state to approximately 3.2 million covered lives.

Vancouver, BC, April 14, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with the Maryland state entity of a major national health insurer, further expanding access to an additional ~2 million members across the state.

Vancouver, BC, March 31, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned subsidiary Rocket Doctor Inc (“Rocket Doctor”) has appointed two additional senior leaders to its team as part of a strategic initiative to advance its digital health platform and marketplace, strengthen product and engineering capabilities, and support continued growth across North America. Dr. Anikia Nelson joins as Director of Product, and Bilal Malik as Director of Engineering, where they will be responsible for overseeing and enhancing product direction, platform innovation, scalability, and platform interoperability - liaising between our clinical and technology teams.

Vancouver, BC, March 24, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with another major California-based health plan, broadening access for an additional 330,000 Medicare Advantage members and more than 1.7 million commercially insured members across the state. Under the agreement, eligible members can access Rocket Doctor’s network of board-certified physicians for a range of medical services, subject to credentialing and plan eligibility.

Vancouver, BC, March 17, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) is pleased to provide an update on the exercise of certain outstanding common share purchase warrants in the company (each a “Warrant”).

Vancouver, BC, March 10, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with another major New York insurer, broadening access for an additional approximate 20,000 Medicare Advantage and Dual-Eligible Medicare Special Needs Plan (D-SNP) members throughout the State. Under the agreement, effective April 1, 2026, eligible members can access Rocket Doctor’s network of board-certified physicians for medical services across New York, pending credentialing and plan eligibility.

Vancouver, BC, March 03, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with another major insurer in New York State, which serves more than 2.4 million members statewide. Under the agreement, eligible members gain in-network access to Rocket Doctor’s network of board-certified physicians, providing medical, behavioral health, and ancillary services across New York, subject to provider credentialing.

Vancouver, BC , Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has entered into a partnership with Lethbridge County, Alberta. This marks the second collaboration with a Canadian municipality to expand access to essential healthcare services virtually, fully covered by Alberta Health with no user fees. The partnership will launch today and automatically renews for subsequent 2-year periods on identical terms.

Vancouver, BC, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has engaged Danayi Capital Corp. (“Danayi”) to provide digital marketing services for a two (2) month term commencing on February 9, 2026, in consideration of an up-front payment of USD$125,000.

Vancouver, BC, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with another major insurer for commercial employer-sponsored health plans in California. Under the agreement, eligible members gain in-network access to Rocket Doctor’s network of board-certified physicians.

Vancouver, BC, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that the Company has granted an aggregate 75,000 stock options, exercisable at $0.74 per share and valid for a term of three years, and an aggregate 212,148 restricted share units, valid for a term of three years, to consultants of the Company.  The stock options and restricted share units are issued pursuant to the Company’s share compensation plans and are subject to vesting over one year.

Vancouver, BC, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced a new partnership with the CAN Health Network to test its AI-powered Clinical Decision Support System (CDSS) in collaboration with Health Cities. The project will launch at up to four primary care sites in Alberta to help physicians deliver faster, evidence-based, and more efficient care.

Vancouver, BC, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that Christopher Cherry shall assume the role of Interim Chief Financial Officer, to replace David Worner, effective December 8, 2025.

Vancouver, BC, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) wholly-owned digital health platform and marketplace Rocket Doctor Inc. (“Rocket Doctor”) today announced a new partnership with Toronto Metropolitan University (TMU) designed to accelerate physician recruitment, promote clinical faculty opportunities, and enhance learner placements with independent physicians on the platform across Canada.

Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) is pleased to announce its financial results for the third quarter ended September 30, 2025. All financial information is presented in Canadian dollars unless otherwise indicated.Dr. Essam Hamza, Chief Executive Officer of Rocket Doctor AI Inc., added: ”Despite expected summer seasonality, we are pleased to report continued sequential organic revenue growth in Q3 compared to Q2. This financial stability, coupled with a successfully oversubscribed capital raise of $4.23 million, underscores investor confidence. Crucially, the period also saw us announce pivotal 'in-network' new payer  agreements in the U.S., These new agreements expand Rocket Doctor Inc’s ability to now deliver care to more than 13 million insured members across California, Maryland and New York State. With the U.S. currently representing ~ 5% of our revenue today, this significant network build positions us for accelerated growth in the U.S. market throughout 2026."Third Quarter 2025 Financial Highlights:

Vancouver, BC, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) wholly-owned digital health platform and marketplace Rocket Doctor Inc. (“Rocket Doctor”) is proud to announce that co-founder and CEO, Dr. Bill Cherniak, was invited to participate in the annual Google Accelerator Alumni Summit in Mexico City last week, joining senior Google leaders and fellow founders to help inform the company’s future product roadmap.

Vancouver, British Columbia, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) Is pleased to announce, further to its news release of January 28, 2025, that it has entered into a definitive share purchase agreement dated November 19, 2025 (the “Definitive Agreement”), amongst the Company, Alea Health Holdings Ltd. (“Alea”) and the ordinary shareholders of Alea (the “Alea Shareholders”) to acquire 100% of the issued and outstanding securities of Alea (the “Proposed Transaction”).

Vancouver, BC, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has granted an aggregate 831,356 restricted share units (“RSUs”) and 20,964 stock options (“Options”) to consultants and employees of the Company and its subsidiary, Rocket Doctor Inc.

Vancouver, BC, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned subsidiary Rocket Doctor Inc (“Rocket Doctor”) has appointed four senior professionals to its leadership team as part of a strategic initiative to accelerate growth, enhance clinical operations, and expand its digital health platform and marketplace, particularly across key U.S. States. The new leaders will oversee key clinical and provider related functions as well as growth and marketing / digital advertising, helping to strengthen payer and community partnerships and advance Rocket Doctor’s coast to coast expansion in the United States.

Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that we have engaged Fundamental Research Corp. (“FRC”), an independent small-cap research firm, for analyst coverage.

New York, NY, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with two new leading U.S. healthcare payers. These new agreements expand Rocket Doctor’s ability to now deliver care to more than 13 million insured members across California and New York State.

Vancouver, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has engaged FN Media Group, LLC (“FN Media”) to commence news/media marketing campaigns for a three (3) day term commencing the week of October 20, 2025, in  consideration of USD$14,085.

Bloomington, Minneapolis, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its US-based subsidiary, Treatment.com Inc. (“Treatment”) in collaboration with Rush River Research has been awarded a highly competitive NIH Small Business Innovation Research (SBIR)  grant from the National Institute on Minority Health and Health Disparities (National Institutes of Health). This Phase 2 award advances the collection of culturally sensitive family medical histories using the application of Artificial Intelligence (AI).

Toronto, ON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., is receiving advisory services and funding of up to $75,000 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop secure communications functionality, and funding of up to $25,000 from the CanExport SMEs program to accelerate product innovation and U.S. market growth.

New York, NY, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with half a dozen major insurance companies across the United States. These agreements provide access to Rocket Doctor’s services for more than 7 million patients across California and New York.

Vancouver, BC, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, due to the Canada Postal Strike, there is a delay in the mailing of the Company’s proxy circular and related documents pertaining to the Company’s Annual General Meeting (the “Meeting”) of the shareholders to be held on Wednesday, October 22, 2025 at the hour of 10:00 a.m. (Pacific Time) at the offices of McMillan LLP, Suite 1500 – 1055 West Georgia Street, Vancouver, British Columbia.

Toronto, ON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has entered into a reseller agreement with Remmie, Inc., the Seattle-based medical device company behind the Remmie 4, an FDA and Health Canada MDEL cleared USB-smart otoscope designed for easy, at-home ear exams.

TORONTO, Ontario, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) a healthcare technology company focused on delivering physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey, is pleased to announce its participation at the upcoming CANTech Letter Investment Conference on Thursday, October 9, 2025, in Toronto, Ontario. Rocket Doctor AI’s CEO, Dr. Essam Hamza, and Founder & CEO of Rocket Doctor Inc., Dr. William Cherniak, will present an overview of the company’s platform, solutions, recent milestones, and growth strategy.2025 CANTech Letter Conference

Vancouver, British Columbia, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has filed a prospectus supplement dated September 22, 2025 (the “Prospectus Supplement”) to its short form base shelf prospectus dated June 10, 2024 (the “Shelf Prospectus”) to qualify the distribution of securities underlying 3,677,400 special warrants (the “Special Warrants”) issued by the Company on August 21, 2025 (the “Offering”).

Baltimore, MD, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with Maryland Medicaid and Medicare. This milestone enables Rocket Doctor to begin serving Maryland residents covered under these public insurance programs through in-network access, improving affordability, coverage, and continuity of care.

Toronto, ON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., has surpassed a major milestone with the expansion of its pharmacy-based virtual care and diagnostic devices program to 50 independently owned pharmacies across Canada with appointments covered by provincial insurance. 

New York, NY , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that doctors using its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., are now in-network with Aetna in New York State, having been fully credentialed for Medicare and commercial plans.

Vancouver, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce its financial results for the second quarter ended June 30, 2025. All financial information is presented in Canadian dollars unless otherwise indicated.

Vancouver, British Columbia, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated 25th July, 2025, it has closed its non-brokered private placement of 3,677,400 special warrants of the Company (each, a “Special Warrant”) at a price of $0.50 per Special Warrant, for aggregate gross proceeds of C$1,838,700 and 4,792,000 units of the Company (each, a “Unit”) at a price of $0.50 per Unit, for aggregate gross proceeds of C$2,396,000 (the “Offering”).